I expect to own EVGN at some point, but I haven’t pounced yet. Fortunately, I haven't missed out on 2013 biotech-IPO boom—my ENTA position is up 67% in just over six months.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”